down arrow

Syncom Formul.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE312C01025
  • NSEID: SYNCOMF
  • BSEID: 524470
INR
16.85
0.51 (3.12%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 17.11 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Part of MojoOne Strategy
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Divi's Lab.
Jagsonpal Pharma
Cipla
Sun Pharma.Inds.
Torrent Pharma
Syncom Formul.
Sigachi Indust.
Hester Bios
Bliss GVS Pharma
Mankind Pharma
Remus Pharma.
Why is Syncom Formulations (India) Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of -80.90% and Operating profit at -73.21% over the last 5 years
2
Stock is technically in a Bearish range
  • The technical trend has deteriorated from Mildly Bearish on 07-Apr-25 and has generated 4.22% returns since then
  • Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
3
With ROE of 11.5, it has a Expensive valuation with a 5.3 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 26.87%, its profits have risen by 48.3% ; the PEG ratio of the company is 0.8
4
Despite the size of the company, domestic mutual funds hold only 0% of the company
  • Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Syncom Formul. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Syncom Formul.
27.17%
0.50
53.48%
SENSEX
0.45%
0.03
14.48%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-80.90%
EBIT Growth (5y)
-73.21%
EBIT to Interest (avg)
17.38
Debt to EBITDA (avg)
1.20
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
16.80
Tax Ratio
25.08%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.13%
ROCE (avg)
127.82%
ROE (avg)
204.14%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
39
Industry P/E
33
Price to Book Value
5.33
EV to EBIT
36.39
EV to EBITDA
32.25
EV to Capital Employed
6.45
EV to Sales
3.78
PEG Ratio
0.81
Dividend Yield
NA
ROCE (Latest)
14.44%
ROE (Latest)
11.51%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

29What is working for the Company
NET SALES(9M)

At Rs 316.13 cr has Grown at 67.42 %

PBDIT(Q)

Highest at Rs 14.73 cr.

PBT LESS OI(Q)

Highest at Rs 13.22 cr.

PAT(9M)

Higher at Rs 31.74 Cr

EPS(Q)

Highest at Rs 0.14

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Syncom Formul.
Net Sales - Quarterly
Highest at Rs 127.53 cr and Grown
each quarter in the last five quarters
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Net Sales - Quarterly
At Rs 127.53 cr has Grown at 55.4 %
over average Net Sales of the previous four quarters of Rs 82.08 Cr
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 14.73 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term Operating Profit trend is quite positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 13.22 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 13.22 cr has Grown at 74.9 %
over average PBT of the previous four quarters of Rs 7.56 Cr
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 13.00 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 13.00 cr has Grown at 56.8 %
over average PAT of the previous four quarters of Rs 8.29 Cr
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 0.14
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)